[ET Net News Agency, 7 January 2026] REMEGEN (09995) rose 10% to HK$89.35.
It hits an intra-day high of HK$89.5, hitting an 1-month high, breaking above the 50-D
SMA of HK$82.538, and an intra-day low of HK$80.5. The total shares traded was 5.62
million, with a value of HK$478.9m. The active buy/sell ratio is 70:30, with net buying
turnover of HK$186.72m. CITIC SEC BRO accounts for greatest net responsive buying turnover
of HK$918,025, with volume weighted average price of HK$87.431. CHINA INV INFO accounts
for greatest net responsive selling turnover of HK$43.85m, with volume weighted average
price of HK$84.977. The stock has risen a combined 24.1% over the past 4 consecutive
trading days.

Basic Information
=================

----------------------------------
Nominal 89.350 % Chg +10.04%
High 89.500 Low 80.500
Shares Tr 5.62m Turnover 478.9m
10-D SMA 77.375 %H.V 60.366
20-D SMA 77.335 VWAP 85.176
50-D SMA 82.538 RSI14 63.234
----------------------------------
Status: Breaking above the 50-D SMA, hitting an 1-month high, active buy/sell ratio is
70:30, with net buying turnover of HK$186.72m, rising a combined 24.1% over the past 4
consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
----------------------------------------------
REMEGEN (09995) 89.35 +10.04
SINO BIOPHARM (01177) 6.67 +1.37
HENGRUI PHARMA (01276) 76.35 +2.41
3SBIO (01530) 27.34 +4.11
KEYMED BIO-B (02162) 58.10 +2.29
WUXI XDC (02268) 66.90 +2.69
ASCENTAGE-B (06855) 54.80 +6.41
SKB BIO-B (06990) 460.00 +4.31
DUALITYBIO-B (09606) 345.20 +1.59
AKESO (09926) 127.10 +5.56
----------------------------------------------
(ed)